la sottomissione degli articoli a Biochimica Clinica (e il successivo processo editoriale) avverrà obbligatoriamente attraverso la piattaforma SCHOLAR ONE.
Qui di seguito il link per il collegamento alla piattaforma.
La segreteria di redazione può essere contattata per ogni necessità al 335 6159776 o all’indirizzo biochimica.clinica@sibioc.it
Member area login
You don't have or don't remember the password! Click Here
Editor-in-chief
Maria Stella Graziani
Deputy Director
Martina Zaninotto
Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali
EIC Assistant
Francesco Busardò
International Advisory Board
Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada
Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano
Responsible Editor
Giuseppe Agosta
Editorial Secretary
Chiara Riva
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it
--------------------
ISSN print: 0393 – 0564
ISSN digital: 0392- 7091
BC: Articoli scritti da T. Scacchetti
Determinazione delle immunoglobuline E specifiche
SIBioC Position statement about in vitro immunoglobulin E (IgE) testing
<p>The aim of this document is to contribute to increase the knowledge of the diagnostic significance and the clinical value of laboratory tests that are included in the in vitro category of allergy tests. In this context, the clinical benefits of the in vitro determination of specific immunoglobulins E (IgE) for complete extracts or single allergen molecules is to be strongly reaffirmed. This test is to be consider central in the diagnostic algorithm of allergic diseases compared to Skin Prick Test.</p>
<p>Gluten hypersensitivity: basophil activation test (BAT) may help in the differential diagnosis? The main forms of gluten-related disorders are wheat allergy (WA), celiac disease (CD) and possibly immune-mediated disease (gluten sensitivity). S-IgE play an essential role in WA. For CD tests available are anti-tissue transglutaminase (tTG) IgA, anti-endomysium (EMA) and deamidated gliadin peptides (DGP) antibodies IgG particular. For other immunemediated diseases there is currently no test available. The usefulness of basophil activation test (BAT) in anaphylactic adverse reactions, late-onset allergy has been demonstrated. We report the case of a woman of 46 years old with disorders of wheat tied overt clinical signs, intestinal and extra-intestinal symptoms, whose tests above were all negative. Only the BAT showed a stimulation of basophils exposed (52.9%) to extract wheat. We diagnosed gluten sensitivity (GS) on the basis of an algorithm for the differential diagnosis of gluten-related disorders, including CD, GS and WA. We believe that the BAT confirms a hypersensitivity reaction to wheat not-IgE-mediated, not CD.</p>
Biochimica Clinica ; 40(4) e31-e34 Casi clinici - Case report
Gentile utente, le ricordiamo che l'accesso alla rivista è riservato ai soci SIBioC in regola con la quota associativa.
Per accedere alla pagina richiesta è necessario inserire il suo nome utente e la password nella sezione "AREA SOCI".
A disposizione per ulteriori informazioni.
La Segreteria SIBioC
Dear User, please note that access to the Journal is for SIBioC members who have renewed their membership fee.
To access the requested page you need to enter username and password in "Area Soci".
At your disposal for further information.
SIBioC Secretariat